Redox has closed a $33 million Series C funding round led by Battery Ventures, with participation from existing investors .406 Ventures, RRE Ventures and Intermountain Ventures, the company announced recently.

“Redox’s success is built on the success of our customers, the most innovative software solutions and healthcare organizations in the market today,” Redox Co-Founder and CEO Luke Bonney said in a statement.

According to a release, the funding comes as Redox has shown customer momentum in its bid to enable faster, more secure and reliable data sharing between healthcare vendors and providers.

The tech company also announced Battery General Partner Chelsea Stoner will join the Redox board.